Free-cash-flow proxy decreased 600.9%
Free-cash-flow proxy changed -600.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed -600.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed -874.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +126.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +47.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +40.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +3983 basis points from the comparable as-filed period.
Operating income changed +25.3% from the comparable as-filed period.
Gross margin changed +365 basis points from the comparable as-filed period.
Revenue changed +55.9% from the comparable as-filed period.
Current assets changed +26.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Shares outstanding changed +24.7% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
Inventory / revenue changed +1787 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed +31.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Trade receivables changed +43.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +68.4% from the comparable as-filed period.
Cost of revenue changed +45.5% from the comparable as-filed period.
SBC / revenue changed -1689 basis points from the comparable as-filed period.
Operating cash-flow margin changed -1962 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed +197.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed +20.5% from the comparable as-filed period.
Capex / revenue changed +231 basis points from the comparable as-filed period.
R&D / revenue changed -1352 basis points from the comparable as-filed period.
Free-cash-flow margin changed -2193 basis points from the comparable as-filed period.
Working capital / assets changed -282 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Receivables / revenue changed -344 basis points from the comparable as-filed period.
Research & development changed +12.8% from the comparable as-filed period.
Stock-based compensation changed -13.9% from the comparable as-filed period.
Current liabilities changed -3.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.